Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study.
Saved in:
| Title: | Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study. |
|---|---|
| Authors: | Simon J; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, Villejuif, France., Chaix M; Medical Oncology Department, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France., Billa O; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France., Kamga AM; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France., Roignot P; Pathology Centre, 33 rue Nicolas Bornier, Dijon, France., Ladoire S; Medical Oncology Department, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France., Coutant C; Surgical Oncology Department, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France., Arveux P; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.; Center for Research in Epidemiology and Population Health, Inserm U1018, Villejuif, France., Quantin C; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, Villejuif, France.; CHRU Dijon, Service de Biostatistiques et d'Information Médicale (DIM), Dijon, 21000, France.; INSERM, CIC 1432, Univ Bourgogne Franche Comte, Dijon, France., Dabakuyo-Yonli TS; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France. sdabakuyo@cgfl.fr.; Inserm U1231 Lipids, Nutrition, Cancer Research Center, Dijon, France. sdabakuyo@cgfl.fr. |
| Source: | British journal of cancer [Br J Cancer] 2020 Sep; Vol. 123 (7), pp. 1071-1077. Date of Electronic Publication: 2020 Jul 17. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32678278 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Simon+J%22">Simon J</searchLink>; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Chaix+M%22">Chaix M</searchLink>; Medical Oncology Department, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Billa+O%22">Billa O</searchLink>; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Kamga+AM%22">Kamga AM</searchLink>; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Roignot+P%22">Roignot P</searchLink>; Pathology Centre, 33 rue Nicolas Bornier, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Ladoire+S%22">Ladoire S</searchLink>; Medical Oncology Department, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Coutant+C%22">Coutant C</searchLink>; Surgical Oncology Department, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Arveux+P%22">Arveux P</searchLink>; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France.; Center for Research in Epidemiology and Population Health, Inserm U1018, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Quantin+C%22">Quantin C</searchLink>; Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, Villejuif, France.; CHRU Dijon, Service de Biostatistiques et d'Information Médicale (DIM), Dijon, 21000, France.; INSERM, CIC 1432, Univ Bourgogne Franche Comte, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Dabakuyo-Yonli+TS%22">Dabakuyo-Yonli TS</searchLink>; Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, 1 rue Professeur Marion, Dijon, France. sdabakuyo@cgfl.fr.; Inserm U1231 Lipids, Nutrition, Cancer Research Center, Dijon, France. sdabakuyo@cgfl.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2020 Sep; Vol. 123 (7), pp. 1071-1077. <i>Date of Electronic Publication: </i>2020 Jul 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32678278 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41416-020-0979-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1071 Titles: – TitleFull: Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Simon J – PersonEntity: Name: NameFull: Chaix M – PersonEntity: Name: NameFull: Billa O – PersonEntity: Name: NameFull: Kamga AM – PersonEntity: Name: NameFull: Roignot P – PersonEntity: Name: NameFull: Ladoire S – PersonEntity: Name: NameFull: Coutant C – PersonEntity: Name: NameFull: Arveux P – PersonEntity: Name: NameFull: Quantin C – PersonEntity: Name: NameFull: Dabakuyo-Yonli TS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2020 Sep Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1532-1827 Numbering: – Type: volume Value: 123 – Type: issue Value: 7 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |
